Literature DB >> 21854742

A mouse mammary tumor virus env-like exogenous sequence is strictly related to progression of human sporadic breast carcinoma.

Chiara Maria Mazzanti1, Mohammad Al Hamad, Giovanni Fanelli, Cristian Scatena, Francesca Zammarchi, Katia Zavaglia, Francesca Lessi, Mauro Pistello, Antonio Giuseppe Naccarato, Generoso Bevilacqua.   

Abstract

A viral etiology of human breast cancer (HBC) has been postulated for decades since the identification of mouse mammary tumor virus (MMTV). The detection of MMTV env-like exogenous sequences (MMTVels) in 30% to 40% of invasive HBCs increased attention to this hypothesis. Looking for MMTVels during cancer progression may contribute to a better understanding of their role in HBC. Herein, we analyzed HBC preinvasive lesions for the presence of MMTVels. Samples were obtained by laser microdissection of FFPE tissues: 20 usual-type ductal hyperplasias, 22 atypical ductal hyperplasias (ADHs), 49 ductal carcinomas in situ (DCISs), 20 infiltrating ductal carcinomas (IDCs), and 26 normal epithelial cells collateral to a DCIS or an IDC. Controls included reductive mammoplastic tissue, thyroid and colon carcinoma, and blood samples from healthy donors. MMTVels were detected by fluorescence-nested PCR. DNA samples from the tissues of nine patients were analyzed by real-time quantitative PCR, revealing a different viral load correlated with stage of progression. Furthermore, as never previously described, the presence of MMTVels was investigated by chromogenic in situ hybridization. MMTVels were found in 19% of normal epithelial cells collateral to a DCIS or an IDC, 27% of ADHs, 82% of DCISs, and 35% of IDCs. No MMTVels were found in the control samples. Quantitative PCR and chromogenic in situ hybridization confirmed these results. These data could contribute to our understanding of the role of MMTVels in HBC.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21854742      PMCID: PMC3181336          DOI: 10.1016/j.ajpath.2011.06.046

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

Review 1.  Update on atypical epithelial hyperplasia and ductal carcinoma in situ.

Authors:  Jean F Simpson
Journal:  Pathology       Date:  2009-01       Impact factor: 5.306

Review 2.  Anatomic markers of human premalignancy and risk of breast cancer.

Authors:  D L Page; W D Dupont
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

3.  Characterization of viral particles isolated from primary cultures of human breast cancer cells.

Authors:  Stella M Melana; Irene Nepomnaschy; Michael Sakalian; Andrea Abbott; Jennifer Hasa; James F Holland; Beatriz G T Pogo
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

Review 4.  Premalignant and malignant mammary lesions induced by MMTV and chemical carcinogens.

Authors:  Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-29       Impact factor: 2.673

5.  Progression from normal breast pathology to breast cancer is associated with increasing prevalence of mouse mammary tumor virus-like sequences in men and women.

Authors:  Caroline E Ford; Margaret Faedo; Roger Crouch; James S Lawson; William D Rawlinson
Journal:  Cancer Res       Date:  2004-07-15       Impact factor: 12.701

6.  A differentiation-based phylogeny of cancer subtypes.

Authors:  Markus Riester; Camille Stephan-Otto Attolini; Robert J Downey; Samuel Singer; Franziska Michor
Journal:  PLoS Comput Biol       Date:  2010-05-06       Impact factor: 4.475

7.  Immunohistochemical detection of a cross-reacting virus antigen in mouse mammary tumors and human breast carcinomas.

Authors:  R Mesa-Tejada; I Keydar; M Ramanarayanan; T Ohno; C Fenoglio; S Spiegelman
Journal:  J Histochem Cytochem       Date:  1978-07       Impact factor: 2.479

8.  Detection of mammary tumor virus env gene-like sequences in human breast cancer.

Authors:  Y Wang; J F Holland; I J Bleiweiss; S Melana; X Liu; I Pelisson; A Cantarella; K Stellrecht; S Mani; B G Pogo
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

9.  Breast cancer incidence highest in the range of one species of house mouse, Mus domesticus.

Authors:  T H Stewart; R D Sage; A F Stewart; D W Cameron
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

10.  Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.

Authors:  Tarek M A Abdel-Fatah; Desmond G Powe; Zsolt Hodi; Jorge S Reis-Filho; Andrew H S Lee; Ian O Ellis
Journal:  Am J Surg Pathol       Date:  2008-04       Impact factor: 6.394

View more
  23 in total

1.  Mouse mammary tumor virus in human breast cancer red herring or smoking gun?

Authors:  Andrew L Mason; Susanna Y Gilady; John R Mackey
Journal:  Am J Pathol       Date:  2011-08-30       Impact factor: 4.307

Review 2.  Presence of a mouse mammary tumour virus-like in feline lymphomas: a preliminary study.

Authors:  Francesca Parisi; Francesca Lessi; Michele Menicagli; Prospero Civita; Romano Liotti; Francesca Millanta; Giulia Freer; Mauro Pistello; Chiara Maria Mazzanti; Alessandro Poli
Journal:  Infect Agent Cancer       Date:  2022-06-23       Impact factor: 3.698

3.  Mouse mammary tumor virus-like virus infection and the risk of human breast cancer: a meta-analysis.

Authors:  Faliang Wang; Jinchao Hou; Qi Shen; Yongfang Yue; Fajun Xie; Xian Wang; Hongchuan Jin
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

4.  Detection of MMTV-Like sequences in Moroccan breast cancer cases.

Authors:  Meriem Slaoui; Mohammed El Mzibri; Rachid Razine; Zineb Qmichou; Mohammed Attaleb; Mariam Amrani
Journal:  Infect Agent Cancer       Date:  2014-11-10       Impact factor: 2.965

5.  Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling.

Authors:  Rebecca Lamb; Gloria Bonuccelli; Béla Ozsvári; Maria Peiris-Pagès; Marco Fiorillo; Duncan L Smith; Generoso Bevilacqua; Chiara Maria Mazzanti; Liam A McDonnell; Antonio Giuseppe Naccarato; Maybo Chiu; Luke Wynne; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Oncotarget       Date:  2015-10-13

Review 6.  Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein-Barr Virus (EBV).

Authors:  James S Lawson; Brian Salmons; Wendy K Glenn
Journal:  Front Oncol       Date:  2018-01-22       Impact factor: 6.244

7.  Prevalence and characteristics of mouse mammary tumor virus-like virus associated breast cancer in China.

Authors:  Fa-Liang Wang; Xiao-Li Zhang; Ming Yang; Jun Lin; Yong-Fang Yue; Ya-Dan Li; Xian Wang; Qiang Shu; Hong-Chuan Jin
Journal:  Infect Agent Cancer       Date:  2021-06-26       Impact factor: 2.965

8.  Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer.

Authors:  Wendy K Glenn; Benjamin Heng; Warick Delprado; Barry Iacopetta; Noel J Whitaker; James S Lawson
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

9.  Human saliva as route of inter-human infection for mouse mammary tumor virus.

Authors:  Chiara Maria Mazzanti; Francesca Lessi; Ivana Armogida; Katia Zavaglia; Sara Franceschi; Mohammad Al Hamad; Manuela Roncella; Matteo Ghilli; Antonio Boldrini; Paolo Aretini; Giovanni Fanelli; Ivo Marchetti; Cristian Scatena; Jacob Hochman; Antonio Giuseppe Naccarato; Generoso Bevilacqua
Journal:  Oncotarget       Date:  2015-07-30

10.  A new immunization and treatment strategy for mouse mammary tumor virus (MMTV) associated cancers.

Authors:  Ori Braitbard; Maayan Roniger; Allan Bar-Sinai; Dana Rajchman; Tamar Gross; Hillel Abramovitch; Marco La Ferla; Sara Franceschi; Francesca Lessi; Antonio Giuseppe Naccarato; Chiara M Mazzanti; Generoso Bevilacqua; Jacob Hochman
Journal:  Oncotarget       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.